Administration of perilla oil coated with calshell increases glucagon-like peptide secretion

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 5, 2008, Pages 1021-1023

  Adachi, Tetsuya ^a   Yanaka, Hiroyuki ^b   Kanai, Hitoshi ^b   Nozaki, Mayu ^b   Takahara, Yoshiyuki ^c   Tsuda, Mariko ^a   Jonouchi, Tatsuya ^a   Tsuda, Kinsuke ^a   Hirasawa, Akira ^a   Tsujimoto, Gozoh ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KITII Co Ltd   (Japan)

^c Pharma Frontier Co Ltd   (Japan)

Author keywords

Calshell; Glucagon like peptide 1; Insulin; Mouse; Perilla oil

Indexed keywords

CALCIUM; GLUCAGON LIKE PEPTIDE 1; INSULIN; PERILLA OIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; HORMONE BLOOD LEVEL; HORMONE RELEASE; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; POWDER;

ALPHA-LINOLENIC ACID; ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GASTRIC JUICE; GLUCAGON-LIKE PEPTIDE 1; INSULIN; INTESTINES; MALE; MICE; MICE, INBRED C57BL; PLANT OILS; POWDERS;

EID: 44349114452     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1021     Document Type: Article

References (26)

1. Uiterwaal C. S., Grobbee D. E., Witteman J. C., van Stiphout W. A., Krauss X. H., Havekes L. M., de Bruijn A. M., van Tol A., Hofman A., Annal. Internal. Med., 121, 576-583 (1994).
2. Zilversmit D. B., Clin. Chem., 41, 153-158 (1995).
3. Roche H. M., Gibney M. J., Lipids, 34, S259-S265 (1999).
4. Kris-Etherton P. M., Harris W. S., Appel L. J., Circulation, 106, 2747-2757 (2002).
5. Ikeda I., Kumamaru J., Nakatani N., Sakono M., Murota I., Imaizumi K., J. Nutr., 131, 1159-1164 (2001).
6. Murata M., Sano Y., Ishihara K., Ushida M., J. Nutr., 132, 742-747 (2002).
7. Yamazaki R. K., Shen T. S., Schade G. B., Biochim. Biophys. Acta, 920, 62-67 (1987).
8. Ide T., Kobayashi H., Ashakumary L., Rouyer I. A., Takahashi Y., Aoyama T., Hashimoto T., Mizugaki M., Biochim. Biophys. Acta, 1485, 23-35 (2000).
9. Kabir Y., Ide T., Biochim. Biophys. Acta, 1304, 105-119 (1996).
10. Osumi T., Hashimoto T., J. Biochem., 85, 131-139 (1979).
11. Roberge J. N., Brubaker P. L., Endocrinology, 128, 3169-3174 (1991).
12. Roberge J. N., Brubaker P. L., Endocrinology, 133, 233-240 (1993).
13. Dumoulin V., Dakka T., Plaisancie P., Chayvialle J. A., Cuber J. C., Endocrinology, 139, 3780-3786 (1998).
14. Rocca A. S., Brubaker P. L., Endocrinology, 140, 1687-1694 (1999).
15. Rocca A. S., LaGreca J., Kalitsky J., Brubaker P. L., Endocrinology, 142, 1148-1155 (2001).
16. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., Tsujimoto G., Nat. Med., 11, 90-94 (2005).
17. Adachi T., Tanaka T., Takemoto K., Koshimizu T. A., Hirasawa A., Tsujimoto G., Biochem. Biophys. Res. Commun., 340, 332-337 (2006).
18. Tanaka T., Yano T., Adachi T., Koshimizu T. A., Hirasawa A., Tsujimoto G., Naunyn Schmiedebergs Arch. Pharmacol., in press.
19. Zheng F., Shi X. W., Yang G. F., Gong L. L., Yuan H. Y., Cui Y. J., Wang Y., Du Y. M., Li Y., Life Sci., 80, 388-396 (2007).
20. Jain A., Gupta Y., Jain S. K., J. Pharm. Pharm. Sci., 10, 86-128 (2007).
21. Jain A., Gupta Y., Jain S. K., J. Drug Target, 15, 285-294 (2007).
22. Kurowska E. M., Dresser G. K., Deutsch L., Vachon D., Khalil W., Prostaglandins Leukot. Essent. Fatty Acids, 68, 207-212 (2003).
23. Society of Japanese Pharmacopoeia, "The Japanese Pharmacopoeia," 15th ed., English Version, Yakuji Nippo, Ltd., Japan, 2006.
24. Tiangson-Bayaga C. L. P., Deveza G. F., Food Sci. Technol. Res., 11, 127-133 (2005).
25. Schirra J., Goke B., Regul. Pept., 128, 109-115 (2005).
26. Irwin N., McClean P. L., Flatt P. R., J. Pept. Sci., 13, 400-405 (2007).